Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Follow-up surgical excision indicated when needle biopsies show ALH or LCIS
May 26th, 2005
According to published research from the United States, "Atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) diagnosed in core needle biopsy (CNB) are generally regarded as risk indicators for developing invasive ductal or lobular carcinoma in either breast. "Currently, there are no well-established guidelines for management of these patients. The most common management options are careful observation and endocrine chemoprophylaxis for high-risk patients." T.M. Elsheikh and J.F. Silverman, Ball Memorial Hospital, Muncie, Indiana, wrote in a review article, "Previous studies had contradicting recommendations regarding follow-up...
Source: Women's Health Weekly (2005-05-26)
|
